SecBot SecBot
144 ·Filed May 5, 2026

ECOR

electroCore, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed5mo ago SEC0001949846-26-000247
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for additional insider filings (Form 4) to confirm actual sales. The persistent selling pattern may indicate management's view of limited upside. However, given the small size, this alone is not a strong sell signal but warrants caution.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
ECOR ▼ -10.01% at T+60d
NEUTRAL call -10.01% · α vs SPY -12.75% · entry $6.99 → $6.29
Entry = T+0 close
May 5, 2026
via day close
T+1d
-4.72%
call -4.72% · α -6.11%
$6.66
settled 6mo ago
T+5d
-5.44%
call -5.44% · α -7.42%
$6.61
settled 6mo ago
T+20d
+35.19%
call +35.19% · α +30.24%
$9.45
settled 5mo ago
T+60d
-10.01%
call -10.01% · α -12.75%
$6.29
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Insider Daniel S. Goldberger (likely an officer/director) filed a Form 144 to sell 25,000 shares of ECOR, valued at approximately $168,000. This follows over 22,000 shares sold in the past month, indicating a pattern of consistent insider selling. While the amount is modest relative to the $54M market cap, the frequency is notable.

Key Facts

  • Form 144 filed on 2026-05-05 for sale of 25,000 shares at ~$168,000.
  • Insider Daniel S. Goldberger sold over 22,000 shares in the prior 30 days across 9 transactions.
  • Recent sales occurred between April 10 and May 4, 2026, at prices around $6 per share.
  • ECOR market cap is $54M; proposed sale represents ~0.3% of market cap.

Financial Impact

$168,000 proposed sale; prior month sales total ~$150,000

insider holdings

Risk Factors

  • Sustained insider selling could signal deteriorating fundamentals or lack of confidence.
  • Low liquidity in ECOR (small-cap) could amplify price impact of insider sales.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001949846-26-000247
Document: 0001949846-26-000247-index.html0001949846-26-000247
Document: 0001949846-26-000247.txt0001949846-26-000247
9 reports for ECOR
Performance horizon
Filters
Rows
Reports for ECOR — sortable, filterable
TypeNow
Sep 9, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$8.99 $9.72▲ +8.12%▲ +6.18%$7.65 (−14.94%)
May 27, 2026
21w ago
144
NEUTRAL ★ 2/10
$9.24 $7.19▼ −22.19%▼ −20.28%$7.65 (−17.24%)
May 14, 2026
23w ago
144
NEUTRAL ★ 2/10
$6.43 $10.25▲ +59.41%▲ +60.27%$7.65 (+18.93%)
May 5, 2026
25w ago
144
NEUTRAL ★ 4/10
$6.99 $9.45▲ +35.19%▲ +30.24%$7.65 (+9.40%)
Apr 29, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$6.15 $9.24▲ +50.24%▲ +44.78%$7.65 (+24.34%)
Apr 23, 2026
26w ago
144
NEUTRAL ★ 3/10
$6.18 $6.13▼ −0.81%▼ −5.44%$7.65 (+23.74%)
Apr 1, 2026
29w ago
Press Release
MIXED ★ 5/10
$6.60 $6.15▼ −6.82%▼ −16.54%$7.65 (+15.87%)
Mar 19, 2026
31w ago
Press Release
MIXED ★ 6/10
$6.25 $6.31▲ +0.96%▼ −8.36%$7.65 (+22.36%)
Mar 10, 2026
33w ago
Press Release
NEUTRAL ★ 3/10
$6.50 $6.21▼ −4.46%▼ −4.31%$7.65 (+17.65%)
Showing 9 of 9

US Market Status

Market Open — Closes in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026